Cas:1001500-41-9 4-amino-N,1-dimethylpyrazole-3-carboxamide manufacturer & supplier

Chemical Name:4-amino-N,1-dimethylpyrazole-3-carboxamide

CAS.NO:1001500-41-9

Synonyms:(4-amino-1-methylpyrazol-3-yl)-N-methylcarboxamide;4-amino-N,1-dimethyl-1H-pyrazole-3-carboxamide;4-amino-1-methyl-1H-pyrazole-3-carboxylic acid methylamide

Molecular Formula:C₆H₁₀N₄O

Molecular Weight:154.17000

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:72.94000

Exact Mass:154.08500

LogP:0.33400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (4-amino-1-methylpyrazol-3-yl)-N-methylcarboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-amino-1-methyl-1H-pyrazole-3-carboxylic acid methylamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4-amino-1-methylpyrazol-3-yl)-N-methylcarboxamide Use and application,4-amino-N,1-dimethyl-1H-pyrazole-3-carboxamide technical grade,usp/ep/jp grade.

Related News: Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. 4-amino-N,1-dimethylpyrazole-3-carboxamide manufacturer The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. 4-amino-N,1-dimethylpyrazole-3-carboxamide supplier Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations. 4-amino-N,1-dimethylpyrazole-3-carboxamide vendor ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� 4-amino-N,1-dimethylpyrazole-3-carboxamide factory Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant.